Press Releases May 5, 2026 04:05 PM

Amwell® Announces Results for First Quarter 2026

Amwell Reports First Quarter 2026 Financial Results and Schedules Investor Conference Call

By Derek Hwang
Share
Twitter Reddit Facebook LinkedIn
AMWL

Amwell, a leading provider of a SaaS-based healthcare technology platform, announced its financial results for Q1 2026 and will hold a conference call to discuss the results. The company continues to offer integrated digital healthcare solutions powering clinical programs for payers and health systems, focusing on enhancing patient access to convenient and effective care.

Amwell® Announces Results for First Quarter 2026
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amwell disclosed Q1 2026 financial results available on their investor website.
  • The company operates a comprehensive SaaS healthcare platform serving millions globally and partners with major health organizations.
  • Amwell emphasizes continuing growth in technology-enabled care solutions for health systems and payers, aiming to improve patient outcomes and access.
  • Sectors impacted include healthcare technology, digital health services, and healthcare providers.

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company’s first quarter earnings report can be viewed at investors.amwell.com.

Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/b826q95x/. A webcast replay will be available for approximately 90 days at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
[email protected]

Investors:
Asher Dewhurst
[email protected]


Risks

  • Financial results details were not included in the announcement, generating uncertainty about earnings performance.
  • Market adoption risks remain as digital healthcare platforms face competitive pressures and regulatory changes.
  • Continued reliance on partnerships with large healthcare organizations may expose the company to operational and contractual risks.

More from Press Releases

Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026 Jun 26, 2026 XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service Jun 26, 2026 Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering Jun 26, 2026 dLocal added to membership of US small-cap Russell 2000® Index Jun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance Jun 26, 2026